PFS serves as a crucial endpoint in oncology studies because it provides insights into the treatment's ability to halt disease progression. Unlike overall survival (OS), which measures the time from diagnosis or start of treatment until death from any cause, PFS focuses solely on the period during which the disease is controlled. This can be particularly valuable for understanding the benefits of a treatment in a shorter time frame.
